Clinical Trial: Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma

Sponsor and Collaborators
H. Lee Moffitt Cancer Center and Research Institute
Millennium Pharmaceuticals, Inc.

Contact
Contact: Christine McIsaac, RN
813-745-1822
christine.mcisaac@moffitt.org

Principal Investigator
Melissa Alsina, MD H. Lee Moffitt Cancer Center and Research Institute

ClinicalTrials.gov Identifier
NCT00948922